Many previous studies have shown that high LAMC1 expression promotes tumor progression and can be used as a prognostic biomarker in many cancers, such as hepatocellular carcinoma, colorectal cancer and endometrial cancer [28, 29]. Here, LAMC1 is linked to cancer.